Infinity cuts drug discovery operations
Thursday, June 16, 2016 - 20:30
in Health & Medicine
Decision comes after a failed clinical trial for the PI3K inhibitor duvelisib
Decision comes after a failed clinical trial for the PI3K inhibitor duvelisib